279 related articles for article (PubMed ID: 27329249)
1. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.
Clancy AA; Spaans JN; Weberpals JI
Ann Oncol; 2016 Sep; 27(9):1696-705. PubMed ID: 27329249
[TBL] [Abstract][Full Text] [Related]
2. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
Xing D; Fadare O
Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
[TBL] [Abstract][Full Text] [Related]
3. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
[No Abstract] [Full Text] [Related]
4. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
[TBL] [Abstract][Full Text] [Related]
5. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma.
Del Pino M; Rodriguez-Carunchio L; Ordi J
Histopathology; 2013 Jan; 62(1):161-75. PubMed ID: 23190170
[TBL] [Abstract][Full Text] [Related]
6. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
[TBL] [Abstract][Full Text] [Related]
7. Molecular Landscape of Vulvar Squamous Cell Carcinoma.
Carreras-Dieguez N; Guerrero J; Rodrigo-Calvo MT; Ribera-Cortada I; Trias I; Jares P; López Del Campo R; Saco A; Munmany M; Marimon L; Ferrando M; Vega N; Del Pino M; Torné A; Ordi J; Rakislova N
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209172
[TBL] [Abstract][Full Text] [Related]
8. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features.
Carreras-Dieguez N; Saco A; Del Pino M; Marimon L; López Del Campo R; Manzotti C; Fusté P; Pumarola C; Torné A; Garcia A; Rakislova N
Histopathology; 2023 Jul; 83(1):17-30. PubMed ID: 37099408
[TBL] [Abstract][Full Text] [Related]
10. Vulvar squamous cell carcinoma arising on human papillomavirus-independent precursors mimicking high-grade squamous intra-epithelial lesion: a distinct and highly recurrent subtype of vulvar cancer.
Carreras-Dieguez N; Saco A; Del Pino M; Pumarola C; Del Campo RL; Manzotti C; Garcia A; Marimon L; Diaz-Mercedes S; Fuste P; Rodrigo-Calvo MT; Vega N; Torné A; Rakislova N
Histopathology; 2023 Apr; 82(5):731-744. PubMed ID: 36593525
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review.
Nitecki R; Feltmate CM
Curr Probl Cancer; 2018 Sep; 42(5):476-485. PubMed ID: 30093165
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
[TBL] [Abstract][Full Text] [Related]
13. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of vulvar squamous cell carcinoma.
Prieske K; Alawi M; Oliveira-Ferrer L; Jaeger A; Eylmann K; Burandt E; Schmalfeldt B; Joosse SA; Woelber L
Gynecol Oncol; 2020 Sep; 158(3):547-554. PubMed ID: 32591094
[TBL] [Abstract][Full Text] [Related]
15. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
[TBL] [Abstract][Full Text] [Related]
16. Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.
Swarts DRA; Voorham QJM; van Splunter AP; Wilting SM; Sie D; Pronk D; van Beurden M; Heideman DAM; Snijders PJF; Meijer CJLM; Steenbergen RDM; Bleeker MCG
Cancer Med; 2018 Sep; 7(9):4542-4553. PubMed ID: 30030907
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways in vulvar squamous cell carcinoma: implications for target therapeutic strategies.
Giulia Mantovani ; Fragomeni SM; Inzani F; Fagotti A; Della Corte L; Gentileschi S; Tagliaferri L; Zannoni GF; Scambia G; Garganese G
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1647-1658. PubMed ID: 32335720
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
[TBL] [Abstract][Full Text] [Related]
19. Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma.
Eva LJ; Sadler L; Fong KL; Sahota S; Jones RW; Bigby SM
Gynecol Oncol; 2020 May; 157(2):450-455. PubMed ID: 32037194
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter methylation of SH3GL2 gene in vulvar squamous cell carcinoma correlates with clinicopathological characteristics and HPV infection status.
Li B; He Y; Han X; Zhang S; Xu Y; Zhou Y; Song Z; Ouyang L
Int J Clin Exp Pathol; 2015; 8(11):15442-7. PubMed ID: 26823912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]